0001127602-23-010145.txt : 20230314
0001127602-23-010145.hdr.sgml : 20230314
20230314190546
ACCESSION NUMBER: 0001127602-23-010145
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230312
FILED AS OF DATE: 20230314
DATE AS OF CHANGE: 20230314
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hill, Mitch C.
CENTRAL INDEX KEY: 0001644989
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39293
FILM NUMBER: 23732682
MAIL ADDRESS:
STREET 1: 1009 TENNYSON DRIVE
CITY: SOUTHLAKE
STATE: TX
ZIP: 76902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inari Medical, Inc.
CENTRAL INDEX KEY: 0001531048
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 452902923
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6001 OAK CANYON, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-923-4747
MAIL ADDRESS:
STREET 1: 6001 OAK CANYON, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: Inceptus Newco1 Inc.
DATE OF NAME CHANGE: 20110923
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2023-03-12
0001531048
Inari Medical, Inc.
NARI
0001644989
Hill, Mitch C.
C/O INARI MEDICAL, INC.
6001 OAK CANYON
IRVINE
CA
92618
1
Chief Financial Officer
Common Stock
2023-03-12
4
M
0
125393
0
A
193285
D
Common Stock
2023-03-13
4
M
0
6500
.457
A
199785
D
Common Stock
2023-03-13
4
S
0
600
56.86
D
199185
D
Common Stock
2023-03-13
4
S
0
1300
58.07
D
197885
D
Common Stock
2023-03-13
4
S
0
4600
59.02
D
193285
D
Common Stock
2023-03-13
4
S
0
600
56.90
D
192685
D
Common Stock
2023-03-13
4
S
0
1700
58.27
D
190985
D
Common Stock
2023-03-13
4
S
0
3950
59.06
D
187035
D
Common Stock
1600
I
By Spouse
Restricted Stock Unit
0
2023-03-12
4
M
0
125393
0
D
Common Stock
125393
0
D
Stock Options (Right to Buy)
.457
2023-03-13
4
M
0
6500
0
D
2029-04-23
Common Stock
6500
152977
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2022.
This transaction was executed in multiple trades at prices ranging from $56.54 to $57.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $57.55 to $58.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $58.58 to $59.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $56.54 to $57.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $57.66 to $58.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $58.66 to $59.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Amount represents the vesting in full of restricted stock units (RSUs) granted under the 2011 Plan in August 2019 that were subject to achievement of certain conditions specified in the award agreement, including continued service to the company. 100% of the RSUs vested on the fourth anniversary of the vesting commencement date as all conditions were satisfied.
Options vested with respect to 25% of the shares on April 30, 2020 and vest with respect to the remaining shares in 36 equal monthly installment thereafter.
/s/ Angela Ahmad, attorney-in-fact for Mitch C. Hill
2023-03-14